• Suppressing hyperlipidemia: triglyceride ↓ and cholesterol ↓;• Suppressing lipogenic gene expression: fatty acid synthase (FAS) ↓;• Enhancing β-oxidation enzyme: carnitine palmitoyltransferase I (CPT1) ↑;• Enhancing mitochondrial function: respiratory control ratio and mitochondrial membrane potential ↑;• Enhancing mitophagy: Frataxin ↑, Parkin ↑, PINK1 ↑, Beclin1 ↑, LC3-II ↑, p62 ↓, CISD1 ↓, VDAC1 ↑, TOM20 ↓ and HIF-1α↓. This evidence concerns the gene FASN and hyperlipidemia.